Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001758866-24-000005
Filing Date
2024-07-31
Accepted
2024-07-31 19:26:36
Documents
1
Period of Report
2024-07-24

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 5579
  Complete submission text file 0001758866-24-000005.txt   7934
Mailing Address 225 FRANKLIN STREET 26TH FLOOR BOSTON MA 02110
Business Address 225 FRANKLIN STREET 26TH FLOOR BOSTON MA 02110 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Issuer) CIK: 0001583648 (see all company filings)

EIN.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 325 RANCH ROAD 620 SOUTH, SUITE 200 AUSTIN TX 78738
Business Address 325 RANCH ROAD 620 SOUTH, SUITE 200 AUSTIN TX 78738 512-531-9088
ADAR1 Partners, LP (Reporting) CIK: 0001758866 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-37471 | Film No.: 241163530

Mailing Address 3503 WILD CHERRY DRIVE BUILDING 9 AUSTIN TX 78738
Business Address 3503 WILD CHERRY DRIVE BUILDING 9 AUSTIN TX 78738 512-254-3790
ADAR1 Capital Management, LLC (Reporting) CIK: 0001940272 (see all company filings)

State of Incorp.: TX | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-37471 | Film No.: 241163531